Offer - Urjas Oil for just ₹ 1 X
Halidace 0.25 Mg Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Schizophrenia. Other than this, Halidace 0.25 Mg Tablet has some other therapeutic uses, which have been discussed ahead.
The right dosage of Halidace 0.25 Mg Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Halidace 0.25 Mg Tablet can also lead to other problems, which have been listed below. Usually, these side effects of Halidace 0.25 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Halidace 0.25 Mg Tablet is Moderate for pregnant women and Severe for women who are breastfeeding. It is important to know if Halidace 0.25 Mg Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Halidace 0.25 Mg Tablet related warnings section.
Halidace 0.25 Mg Tablet is contraindicated in people with pre-existing medical conditions like Depression, Arrhythmia, Bradycardia (Slow Heart Rate) as it can result in adverse effects. Other conditions have been mentioned below in the Halidace 0.25 Mg Tablet contraindications section.
Additionally, Halidace 0.25 Mg Tablet may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Halidace 0.25 Mg Tablet is not safe while driving, and is is not addictive in nature.
Halidace 0.25 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Halidace 0.25 Mg Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Halidace. It is best to stop taking Halidace immediately and inform your doctor if you notice any discomfort.
Is the use of Halidace 0.25 Mg Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Halidace. So it is adviced to consult the doctor before using it.
What is the effect of Halidace 0.25 Mg Tablet on the Kidneys?
Using Halidace does not have any harmful effects on kidneys.
What is the effect of Halidace 0.25 Mg Tablet on the Liver?
Halidace has very mild side effects on the liver.
What is the effect of Halidace 0.25 Mg Tablet on the Heart?
Side effects of Halidace rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Halidace 0.25 Mg Tablet unless your doctor advises you to do so -
Is this Halidace 0.25 Mg Tablet habit forming or addictive?
Halidace 0.25 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Halidace 0.25 Mg Tablet, you should not drive or work on any heavy machine, as Halidace 0.25 Mg Tablet can make you drowsy.
Is it safe?
Yes, but take Halidace 0.25 Mg Tablet only as per medical advice.
Is it able to treat mental disorders?
Yes, in many cases, taking Halidace 0.25 Mg Tablet can help with mental disorders.
Interaction between Food and Halidace 0.25 Mg Tablet
It is safe to take Halidace 0.25 Mg Tablet with food.
Interaction between Alcohol and Halidace 0.25 Mg Tablet
Consult your doctor before consuming alcohol while taking Halidace 0.25 Mg Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 633-634
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 441
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Haldol® (haloperidol)